Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-22-000054
Filing Date
2022-05-24
Accepted
2022-05-24 16:13:06
Documents
1
Period of Report
2022-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165342316015735.html 4  
1 FORM 4 wf-form4_165342316015735.xml 4 5500
  Complete submission text file 0001439222-22-000054.txt   6944
Mailing Address C/O BIOGEN IDEC INC. 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address
Clancy Paul J (Reporting) CIK: 0001409601 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 22956782

Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations